Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-18, Stock:LLY, The news for the past five days is as follows:
2019-07-11: NEWS1: Drug distributors surge, drug makers tumble after Trump administration reverses stance on rebates.NEWS2: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS3: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS4: 4 Drug Stocks Getting Smashed.NEWS5: The Zacks Analyst Blog Highlights: Bank of America, Eli Lilly, Boston Scientific, Schwab and Advanced Micro Devices.NEWS6: The Zacks Analyst Blog Highlights: Bank of America, Eli Lilly, Boston Scientific, Schwab and Advanced Micro Devices.NEWS7: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS8: The Zacks Analyst Blog Highlights: Bank of America, Eli Lilly, Boston Scientific, Schwab and Advanced Micro Devices.NEWS9: UPDATE 1-Eli Lilly's bio-medicines head to leave next month.NEWS10: Eli Lilly's bio-medicines head to leave next month.NEWS11: Lilly Announces Changes in Senior Leadership.NEWS12: New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality® (galcanezumab-gnlm) in Episodic Cluster Headache.NEWS13: Stocks -  Health Insurers Drive Dow to New Record at Opening.
2019-07-12: NEWS1: Drug Pricing Woes Linger on Repealing Drug Rebate Proposal.NEWS2: Drug Pricing Woes Linger on Repealing Drug Rebate Proposal.NEWS3: S&P 500 Movers: ILMN, JBHT.NEWS4: S&P 500 Movers: ILMN, JBHT.NEWS5: Drug Pricing Woes Linger on Repealing Drug Rebate Proposal.NEWS6: Health Care stocks help lead Wall Street rally.NEWS7: Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug.NEWS8: Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine.NEWS9: AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of Emgality® (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine.
2019-07-15: nan
2019-07-16: NEWS1: Alkermes to Include Bipolar I Disorder in ALKS 3831 NDA.NEWS2: Here's a Prescription for Eli Lilly Stock: Don't Swallow Yet.NEWS3: Alkermes to Include Bipolar I Disorder in ALKS 3831 NDA.NEWS4: Jim Cramer Weighs In On Marvell, General Motors And More.
2019-07-17: NEWS1: IWV, LLY, BKNG, MDLZ: Large Outflows Detected at ETF.NEWS2: IWV, LLY, BKNG, MDLZ: Large Outflows Detected at ETF.NEWS3: AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer™, an Investigational Treatment for Alzheimer’s Disease.

Answer: Rise